Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
07 April 2016Website:
http://www.spyre.comNext earnings report:
09 August 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Fri, 05 Jul 2024 20:38:17 GMTDividend
Analysts recommendations
Institutional Ownership
SYRE Latest News
WALTHAM, Mass. , June 3, 2024 /PRNewswire/ -- Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the "Company" or "Spyre"), a development-stage biotechnology company advancing best-in-class antibody engineering, rational therapeutic combinations, and precision medicine approaches for the treatment of Inflammatory Bowel Disease ("IBD"), today announced that Spyre's independent Compensation Committee of the Board of Directors approved the grants of stock options to purchase an aggregate of 83,000 shares of common stock of Spyre to 3 non-executive employees as equity inducement awards under the Spyre Therapeutics, Inc. 2018 Equity Inducement Plan, as amended (the "2018 Plan").
After losing some value lately, a hammer chart pattern has been formed for Spyre Therapeutics (SYRE), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
What type of business is Spyre Therapeutics?
Spyre Therapeutics, Inc., a biotechnology company, focuses on advancing a pipeline of antibody therapeutics for the treatment of inflammatory bowel disease by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. The company's pipeline includes extended half-life antibodies targeting a4ß7, TL1A, and IL-23. The company was formerly known as Aeglea BioTherapeutics, Inc. and changed its name to Spyre Therapeutics, Inc. in November 2023. Spyre Therapeutics, Inc. was founded in 2013 and is based in Waltham, Massachusetts.
What sector is Spyre Therapeutics in?
Spyre Therapeutics is in the Healthcare sector
What industry is Spyre Therapeutics in?
Spyre Therapeutics is in the Biotechnology industry
What country is Spyre Therapeutics from?
Spyre Therapeutics is headquartered in United States
When did Spyre Therapeutics go public?
Spyre Therapeutics initial public offering (IPO) was on 07 April 2016
What is Spyre Therapeutics website?
https://www.spyre.com
Is Spyre Therapeutics in the S&P 500?
No, Spyre Therapeutics is not included in the S&P 500 index
Is Spyre Therapeutics in the NASDAQ 100?
No, Spyre Therapeutics is not included in the NASDAQ 100 index
Is Spyre Therapeutics in the Dow Jones?
No, Spyre Therapeutics is not included in the Dow Jones index
When does Spyre Therapeutics report earnings?
The next expected earnings date for Spyre Therapeutics is 09 August 2024